The Role of Biomarkers in HR-Positive/HER2-Negative Early Breast Cancer: From Clinical Analysis to Clinical Decisions

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-27-2026 3PM EDT 4 min · 27 Sep 2026 · NPR News Now

The Saint: Fishes Gotta Eat 04/29/1951 29 min · 27 Sep 2026 · Choice Classic Radio Detectives | Old Time Radio

280926 money diary 44 min · 27 Sep 2026 · She's On The Money

Electric Cars: He went for a Prado, bought a Tesla - plus, New or Used? 40 min · 27 Sep 2026 · Two Blokes Talking Tech

The Global Story: Why the world wants American surrogates 30 min · 27 Sep 2026 · Global News Podcast

AI is eating the world’s books 16 min · 27 Sep 2026 · 7am

Report any issue

Source

Recorded25 Feb 2022

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:4299943

Show notes

Watch this 4-part discussion with expert pathologists and oncologists on the latest strategies for biomarker testing and treatment planning. Credit available for this activity expires: 2/24/2023 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/968999?src=mkm_podcast_addon_968999

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in